A carregar...
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug–drug interaction
INTRODUCTION: Erlotinib is a FDA approved small molecule inhibitor of epidermal growth factor receptor and dovitinib is a novel small molecule inhibitor of fibroblast growth factor and vascular endothelial growth factor receptor. This phase 1 trial was conducted to characterize the safety and determ...
Na minha lista:
| Publicado no: | Lung Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613811/ https://ncbi.nlm.nih.gov/pubmed/26149476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2015.06.011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|